Why Pfizer's 2017 Was Mediocre at Best Post author:Sam Post published:December 12, 2017 Post category:BioPharma Pfizer’s 2017 wasn’t horrible. Just ho-hum. Source: BioSpace You Might Also Like <b>Rosalind Franklin University</b> Researcher Awarded $2 Million From NIH To Study Role Of Hormone Oxytocin In Stress, Fear and Anxiety August 17, 2017 Adaptimmune Announces Closing Of $42 Million Registered Direct Offering April 10, 2017 Vioguard Signs Agreement With Of Saudi Arabia To Represent Vioguard In The Middle East April 2, 2017
<b>Rosalind Franklin University</b> Researcher Awarded $2 Million From NIH To Study Role Of Hormone Oxytocin In Stress, Fear and Anxiety August 17, 2017
